“If we can actually decrease the failure rate from nine out of 10 drugs failing in clinical trials and instead have seven out of 10 instead failing, that is a major victory for drug discovery and for people having better therapy.”

Anne Wojcicki is a Silicon Valley entrepreneur and philanthropist. She co-founded 23andMe, a company pioneering genetic testing and personalized health data, and later launched Verily, a life sciences research arm of Alphabet. Her work centers on merging technology with medicine to advance preventive healthcare and genetic research.